Abstract
Cell models have been useful for elucidating the function of proteins and/or their role in pathogenesis. Even before the discovery that the prion protein was a normal cellular protein (Oesch et al. Cell 40 (4):735–746, 1985), cell models were developed to investigate prion infection (Rubenstein et al. J Gen Virol 65 (Pt 12):2191–2198, 1984). Subsequently, with the discovery of familial forms of human prion diseases (Hsiao et al. Nature 338 (6213):342–345, 1989), cell models were developed to investigate the effect of mutations on the metabolism of the prion protein and, in parallel, the normal synthesis and processing of the cellular prion protein. In this chapter, we review the progress made in these two areas to date.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barret A, Tagliavini F, Forloni G, Bate C, Salmona M, Colombo L, De Luigi A, Limido L, Suardi S, Rossi G, Auvre F, Adjou KT, Sales N, Williams A, Lasmezas C, Deslys JP (2003) Evaluation of quinacrine treatment for prion diseases. J Virol 77(15):8462–8469
Bate C, Williams A (2012) Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins. J Biol Chem 287(11):7935–7944. doi:10.1074/jbc.M111.275743
Beringue V, Vilette D, Mallinson G, Archer F, Kaisar M, Tayebi M, Jackson GS, Clarke AR, Laude H, Collinge J, Hawke S (2004) PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem 279(38):39671–39676. doi:10.1074/jbc.M402270200
Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, Bostock CJ (2001) Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20(13):3351–3358. doi:10.1093/emboj/20.13.3351
Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110(3):743–752
Bosque PJ, Prusiner SB (2000) Cultured cell sublines highly susceptible to prion infection. J Virol 74(9):4377–4386
Browning S, Baker CA, Smith E, Mahal SP, Herva ME, Demczyk CA, Li J, Weissmann C (2011) Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication. J Biol Chem 286(47):40962–40973. doi:10.1074/jbc.M111.283978
Butler DA, Scott MR, Bockman JM, Borchelt DR, Taraboulos A, Hsiao KK, Kingsbury DT, Prusiner SB (1988) Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62(5):1558–1564
Capellari S, Parchi P, Russo CM, Sanford J, Sy MS, Gambetti P, Petersen RB (2000a) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157(2):613–622
Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000b) The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2(1):27–35
Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67(2):643–650
Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63(1):175–181
Caughey B, Neary K, Buller R, Ernst D, Perry LL, Chesebro B, Race RE (1990) Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J Virol 64(3):1093–1101
Caughey B, Raymond GJ, Ernst D, Race RE (1991) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65(12):6597–6603
Clarke MC, Haig DA (1970a) Evidence for the multiplication of scrapie agent in cell culture. Nature 225(5227):100–101
Clarke MC, Haig DA (1970b) Multiplication of scrapie agent in cell culture. Res Vet Sci 11(5):500–501
Cohen E, Taraboulos A (2003) Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J 22(3):404–417. doi:10.1093/emboj/cdg045
Cronier S, Laude H, Peyrin JM (2004) Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 101(33):12271–12276. doi:10.1073/pnas.0402725101
Dlakic WM, Grigg E, Bessen RA (2007) Prion infection of muscle cells in vitro. J Virol 81(9):4615–4624. doi:10.1128/JVI.02628-06
Enari M, Flechsig E, Weissmann C (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA 98(16):9295–9299. doi:10.1073/pnas.151242598
Feraudet C, Morel N, Simon S, Volland H, Frobert Y, Creminon C, Vilette D, Lehmann S, Grassi J (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 280(12):11247–11258. doi:10.1074/jbc.M407006200
Follet J, Lemaire-Vieille C, Blanquet-Grossard F, Podevin-Dimster V, Lehmann S, Chauvin JP, Decavel JP, Varea R, Grassi J, Fontes M, Cesbron JY (2002) PrP expression and replication by Schwann cells: implications in prion spreading. J Virol 76(5):2434–2439
Gabizon R, Meiner Z, Halimi M, Ben-Sasson SA (1993) Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J Cell Physiol 157(2):319–325. doi:10.1002/jcp.1041570215
Gilch S, Wopfner F, Renner-Muller I, Kremmer E, Bauer C, Wolf E, Brem G, Groschup MH, Schatzl HM (2003) Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J Biol Chem 278(20):18524–18531. doi:10.1074/jbc.M210723200
Giri RK, Young R, Pitstick R, DeArmond SJ, Prusiner SB, Carlson GA (2006) Prion infection of mouse neurospheres. Proc Natl Acad Sci USA 103(10):3875–3880. doi:10.1073/pnas.0510902103
Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338(6213):342–345. doi:10.1038/338342a0
Iwamaru Y, Takenouchi T, Ogihara K, Hoshino M, Takata M, Imamura M, Tagawa Y, Hayashi-Kato H, Ushiki-Kaku Y, Shimizu Y, Okada H, Shinagawa M, Kitani H, Yokoyama T (2007) Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J Virol 81(3):1524–1527. doi:10.1128/JVI.01379-06
Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C (2003) A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 100(20):11666–11671. doi:10.1073/pnas.1834432100
Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B (2003) New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 77(19):10288–10294
Lehmann S, Harris DA (1995) A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J Biol Chem 270(41):24589–24597
Lehmann S, Harris DA (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271(3):1633–1637
Lehmann S, Harris DA (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272(34):21479–21487
Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry (Mosc) 38(11):3258–3267
Locht C, Chesebro B, Race R, Keith JM (1986) Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci USA 83(17):6372–6376
Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 98(26):14955–14960. doi:10.1073/pnas.011578098
Ma J, Wollmann R, Lindquist S (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298(5599):1781–1785. doi:10.1126/science.1073725
Maas E, Geissen M, Groschup MH, Rost R, Onodera T, Schatzl H, Vorberg IM (2007) Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. J Biol Chem 282(26):18702–18710. doi:10.1074/jbc.M701309200
Markovits P, Dautheville C, Dormont D, Dianoux L, Latarjet R (1983) In vitro propagation of the scrapie agent. I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506. Acta Neuropathol 60(1–2):75–80
McKinley MP, Taraboulos A, Kenaga L, Serban D, Stieber A, DeArmond SJ, Prusiner SB, Gonatas N (1991) Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 65(6):622–630
Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S (2000) Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97(25):13937–13942. doi:10.1073/pnas.250289197
Milhavet O, Casanova D, Chevallier N, McKay RD, Lehmann S (2006) Neural stem cell model for prion propagation. Stem Cells 24(10):2284–2291. doi:10.1634/stemcells.2006-0088
Mishra RS, Gu Y, Bose S, Verghese S, Kalepu S, Singh N (2002) Cell surface accumulation of a truncated transmembrane prion protein in Gerstmann-Straussler-Scheinker disease P102L. J Biol Chem 277(27):24554–24561
Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, Casanova D, Milhavet O, Lehmann S (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74(1):320–325
Nunziante M, Gilch S, Schatzl HM (2003) Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J Biol Chem 278(6):3726–3734. doi:10.1074/jbc.M206313200
Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE et al (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40(4):735–746
Ostlund P, Lindegren H, Pettersson C, Bedecs K (2001) Altered insulin receptor processing and function in scrapie-infected neuroblastoma cell lines. Brain Res Mol Brain Res 97(2):161–170
Parchi P, Capellari S, Chin S, Schwarz HB, Schecter NP, Butts JD, Hudkins P, Burns DK, Powers JM, Gambetti P (1999) A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 52(9):1757–1763
Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412(6848):739–743. doi:10.1038/35089090
Perrier V, Solassol J, Crozet C, Frobert Y, Mourton-Gilles C, Grassi J, Lehmann S (2004) Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem 89(2):454–463. doi:10.1111/j.1471-4159.2004.02356.x
Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271(21):12661–12668
Pimpinelli F, Lehmann S, Maridonneau-Parini I (2005) The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines. Eur J Neurosci 21(8):2063–2072. doi:10.1111/j.1460-9568.2005.04049.x
Race R (1991) The scrapie agent in vitro. Curr Top Microbiol Immunol 172:181–193
Race RE, Fadness LH, Chesebro B (1987) Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol 68(Pt 5):1391–1399
Robakis NK, Devine-Gage EA, Jenkins EC, Kascsak RJ, Brown WT, Krawczun MS, Silverman WP (1986) Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem Biophys Res Commun 140(2):758–765
Rubenstein R, Carp RI, Callahan SM (1984) In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol 65(Pt 12):2191–2198
Rubenstein R, Deng H, Scalici CL, Papini MC (1991) Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. J Gen Virol 72(Pt 6):1279–1285
Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, Dwek RA (1999) Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci USA 96(23):13044–13049
Rudd PM, Wormald MR, Wing DR, Prusiner SB, Dwek RA (2001) Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry (Mosc) 40(13):3759–3766
Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB (1997) A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 71(11):8821–8831
Sigurdsson EM, Sy MS, Li R, Scholtzova H, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T (2003) Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett 336(3):185–187
Singh N, Zanusso G, Chen SG, Fujioka H, Richardson S, Gambetti P, Petersen RB (1997) Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J Biol Chem 272(45):28461–28470
Solomon IH, Schepker JA, Harris DA (2010) Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol 12(2):51–61
Taraboulos A, Serban D, Prusiner SB (1990) Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol 110(6):2117–2132
Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129(Pt 9):2241–2265. doi:10.1093/brain/awl150
Turnbull J, Powell A, Guimond S (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11(2):75–82
Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, Laude H (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 98(7):4055–4059. doi:10.1073/pnas.061337998
Vorberg I, Raines A, Story B, Priola SA (2004) Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis 189(3):431–439. doi:10.1086/381166
White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422(6927):80–83. doi:10.1038/nature01457
Winklhofer KF, Hartl FU, Tatzelt J (2001) A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett 503(1):41–45
Zaidi SI, Richardson SL, Capellari S, Song L, Smith MA, Ghetti B, Sy MS, Gambetti P, Petersen RB (2005) Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding. J Alzheimers Dis 7(2):159–171, discussion 173–180
Zanusso G, Petersen RB, Jin T, Jing Y, Kanoush R, Ferrari S, Gambetti P, Singh N (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem 274(33):23396–23404
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rubenstein, R., Petersen, R.B. (2013). Modeling the Cell Biology of Prions. In: Zou, WQ., Gambetti, P. (eds) Prions and Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5305-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5305-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5304-8
Online ISBN: 978-1-4614-5305-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)